Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Saudi Arabia. | Cancer Rep (Hoboken) | 2023 | 36806724 | PubTator, text mining | PubMed |
| Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors. | Neoplasia | 2023 | 36804751 | PubTator, text mining | PubMed |
| Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. | J Natl Med Assoc | 2023 | 36801148 | PubTator, text mining | PubMed |
| Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36797231 | PubTator, text mining | PubMed |
| Implementation and clinical benefit of DPYD genotyping in a Danish cancer population. | ESMO Open | 2023 | 36791638 | PubTator, text mining | PubMed |
| Energy decomposition and waterswapping analysis to investigate the SNP associated DPD mediated 5-FU resistance. | SAR QSAR Environ Res | 2023 | 36779961 | PubTator, text mining | PubMed |
| PAnno: A pharmacogenomics annotation tool for clinical genomic testing. | Front Pharmacol | 2023 | 36778023 | PubTator, text mining | PubMed |
| Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase. | J Biol Chem | 2023 | 36773803 | PubTator, text mining | PubMed |
| The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. | Int J Mol Sci | 2023 | 36769170 | PubTator, text mining | PubMed |
| Integrated Intensified Chemoradiation in the Setting of Total Neoadjuvant Therapy (TNT) in Patients with Locally Advanced Rectal Cancer: A Retrospective Single-Arm Study on Feasibility and Efficacy. | Cancers (Basel) | 2023 | 36765878 | PubTator, text mining | PubMed |
| Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program. | Cancers (Basel) | 2023 | 36765865 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic Data. | Cancers (Basel) | 2023 | 36765773 | PubTator, text mining | PubMed |
| Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. | Cancers (Basel) | 2023 | 36765737 | PubTator, text mining | PubMed |
| Routine DPYD Genetic Testing. | J Clin Oncol | 2023 | 36763913 | PubTator, text mining | PubMed |
| Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice. | J Biol Rhythms | 2023 | 36762608 | PubTator, text mining | PubMed |
| Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis. | Clin Transl Sci | 2023 | 36760155 | PubTator, text mining | PubMed |
| Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. | Cell Commun Signal | 2023 | 36759799 | PubTator, text mining | PubMed |
| Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapy. | Eur J Clin Pharmacol | 2023 | 36757428 | PubTator, text mining | PubMed |
| In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. | Cancer Cell Int | 2023 | 36717845 | PubTator, text mining | PubMed |
| Sex differences in drug effects and/or toxicity in oncology. | Curr Res Pharmacol Drug Discov | 2023 | 36714036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=31